News | News By Subject | News by Disease News By Date | Search News

Investor News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Celgene (CELG), Merck & Co. (MRK) Prime Examples of Novel Science "Renaissance," Says VC     1/29/2015
The Coming Crash in Biotech Stocks     1/28/2015
With Profits Down By 52 Percent, Pfizer (PFE) Investors May Pressure for an M&A, a Breakup, or Both     1/28/2015
BioSpace (DHX)'s List of Five Companies to Watch in 2015: Aegerion (AEGR), AbbVie (ABBV), Tekmira (TKMR), Novartis AG (NVS), GlaxoSmithKline (GSK)     1/28/2015
EXCLUSIVE: Novartis AG (NVS), Amgen (AMGN) and Pfizer (PFE)’s Push Into Early Stages Exciting, But “Secret Sauce” Is Crucial, Says VC     1/28/2015
Amgen (AMGN) Beats Street’s Earnings Estimates, Ready for Biosimilars, Says Citi     1/27/2015
Scandal-Hit GlaxoSmithKline (GSK) to Chop 1,000 Staffers in China     1/27/2015
New Contestant Named in Best Hair in Biopharma As Race for Crown Heats Up     1/22/2015
Biotech IPOs Up 22% Since "Bubble" Year of 2000, Shows New Data     1/19/2015
J.P. Morgan: bluebird bio (BLUE) Soars On CEO's Sickle Cell Data     1/16/2015
J.P. Morgan: Juno Therapeutics (JUNO) Touts 10 New Drugs for Six Diseases, Loves New CAR-T Platform     1/16/2015
J.P. Morgan: AstraZeneca PLC (AZN) CEO Says He's Not Worried About Pricing Pressure     1/15/2015
J.P. Morgan: Valeant (VRX) Investors Should Expect "Small and Medium Sized" Deals in 2015, Says CFO     1/13/2015
Merck & Co. (MRK) Issues Updates on Strategic Initiatives, Opportunities     1/13/2015
J.P. Morgan: Express Scripts Inc. CEO Said it Will Take On Cancer Drug Pricing Next     1/13/2015

Featured Stories
Biotechs To Follow In 2015 Off Fresh Insider Moves     1/7/2015
Batu Biologics Releases 2014 Shareholder Letter     1/2/2015
Race Heats Up for Best Hair in Biopharma Contest As Celgene (CELG), Acorda Therapeutics (ACOR) Square Off     12/2/2014
Investors Expect Record Year for Biotech Venture Capital     11/25/2014
Exclusive: Fewer Deals, Capital In Biotech In Q3 But Sector Remains Popular, Says VC     10/20/2014
Full Blown Ebola Epidemic Unlikely In U.S., Says Specialist     10/20/2014
Current Climate The Best For Biotech IPOs In Decades, Says VC     10/20/2014
Walking Dead: Biotech "Zombie" Companies And Why They Are Failing     10/15/2014
BioSpace's List Of The Top 5 Biggest VC Vampires In Biotech     10/10/2014
Cross-Over Investing All The Rage, Say VCs On Panel     10/9/2014
Traders’ Infatuation With Ebola Drugs Causing “Rollercoaster” Market, Says Tekmira (TKMR) CEO     10/8/2014
Venture Capital Pours Into Biotech For Biggest Quarter Since 2012: Report     10/3/2014
Biotech Boom On Third Coast Proves Everything's Bigger In Texas     10/3/2014
What Happened At BioPharm America 2014?     9/24/2014
Move Over San Francisco: Boston Showing Its Pharmaceutical Potential     8/26/2014
Mylan Inc. (MYL) Shareholders Overwhelmingly Approve Agreement Implementing Acquisition Of Abbott Laboratories (ABT)'s Non-U.S. Developed Markets Specialty And Branded Generics Business     1/29/2015
InVivo Therapeutics Corporation (NVIV) Announces $12 Million Registered Direct Offering     1/29/2015
Omeros Corporation (OMER) Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants     1/29/2015
Mirati Therapeutics  (MRTX) Announces Proposed Public Offering Of Common Stock     1/29/2015
OXIS International, Inc. (OXIS) Announces Approval For Up-Listing To The OTCQB     1/29/2015
Auspex Pharmaceuticals (ASPX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares     1/29/2015
Zafgen (ZFGN) Announces Closing Of Public Offering Of Common Stock And Full-Exercise Of Option To Purchase Additional Shares     1/29/2015
Otonomy, Inc. (OTIC) Announces Closing Of Follow-On Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares     1/29/2015
Vitae Pharmaceuticals, Inc. (VTAE) Announces Exercise Of Underwriters' Option To Purchase Additional Shares And Closing Of Follow-On Public Offering Of Common Stock     1/29/2015
Oxford Immunotec Limited (OXFD) Announces Proposed Underwritten Offering Of Ordinary Shares     1/29/2015
XenoPort, Inc. (XNPT) Announces Pricing Of $100 Million 2.50% Convertible Senior Notes Due 2022     1/29/2015
Salix Pharmaceuticals, Ltd. (SLXP) Provides Update On Audit Committee Review     1/29/2015
Cleveland Biolabs Inc. (CBLI) Announces Results Of Special Meeting Of Stockholders And Reverse Stock Split     1/29/2015
Future Of Healthcare Investor Forum Highlights Investment Opportunity In UK Life Sciences     1/29/2015
Vaccinogen Closes Second Tranche Of $80 Million Financing At $5.50 Per Unit     1/28/2015

More News
No News Posted on that date

Career Tips
Where Does Sanofi (SAN.PA) Find the Best Employees?     1/23/2015
Genentech (RHHBY) Reveals Their Greatest Source of Who They Hire     1/22/2015
6 Rules Every Biotech Job Seeker Should Know     1/22/2015
6 Things You Must Know When Working With Recruiters, HR, and Hiring Managers     1/22/2015
The Ultimate Secret of Acing Behavioral Interviews     1/22/2015
Quit AND Collect Unemployment     1/8/2015
7 Job Search Tips For 2015 From Top Career Experts     1/8/2015
50 Most Common Interview Questions     1/8/2015
How To Revamp Your Resume For The 10-Second Initial Review     1/8/2015
How To Get Noticed By Employers: Advice From Cliniqa And DexCom (DXCM)     12/18/2014
Best Cover Letter Tips For 2015     12/18/2014
Top 10 Resume Tips For 2015     12/18/2014
5 Crucial Cover Letter Mistakes     12/18/2014
What AstraZeneca PLC (AZN) Is Looking For In Hiring Scientists And Execs     12/5/2014
3 Cover Letter Mistakes You May Not Realize You've Made     12/4/2014

Other News Sources
Editorial Corner
Editorial Inquiries & Guest Submissions
Rosemary Do
415-315-9737
rosemary.do@biospace.com

Press Release Submissions
Post your news
news@biospace.com
//-->